FOXD1 and colorectal cancer: In addition, CXCL5 is positively correlated with the micro-vessel marker CD31, and it activates the AKT/NF-kB/FOXD1/VEGF-A pathway to enhance its tube formation ability in a CXCR2-dependent manner in colorectal cancer [33].